Literature DB >> 12226817

Genetic variation of hepatitis B surface antigen coding region among infants with chronic hepatitis B virus infection.

Omana V Nainan1, Marina L Khristova, KwanSoo Byun, Guoliang Xia, Patricia E Taylor, Cladd E Stevens, Harold S Margolis.   

Abstract

Variants in the amino acid composition of the primary antibody-binding site of hepatitis B surface antigen (HBsAg) have been identified in a number of populations with chronic hepatitis B virus (HBV) infection. Direct sequencing of amplified or cloned PCR products, solid phase detection of sequence-specific PCR products (SP-PCR), and limiting dilution cloning PCR (LDC-PCR) were compared to determine their sensitivity in detecting differing concentrations of HBsAg variants. LDC-PCR had the greatest sensitivity and could detect HBsAg variants at a concentration of 0.1% of the total viral population. HBsAg variants were detected in 51% of infants with chronic HBV infection acquired after postexposure prophylaxis, and more than half of the variants were detected only by the most sensitive methods. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12226817     DOI: 10.1002/jmv.10206

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  19 in total

1.  Antigenic and immunogenic changes due to mutation of s gene of HBV.

Authors:  Jun-Hui Ge; Hui-Min Liu; Jing Sun; Le-Zhi Zhang; Jin He; Yu-Li Li; Hong Liu; Yi Xu; Hong-Yu Yu; Yi-Ping Hu
Journal:  World J Gastroenterol       Date:  2004-11-01       Impact factor: 5.742

2.  Detection of rtN236T and rtA181V/T mutations associated with resistance to adefovir dipivoxil in samples from patients with chronic hepatitis B virus infection by the INNO-LiPA HBV DR line probe assay (version 2).

Authors:  Carla Osiowy; Jean-Pierre Villeneuve; E Jenny Heathcote; Elizabeth Giles; Jamie Borlang
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

Review 3.  Viral and cellular determinants involved in hepadnaviral entry.

Authors:  Dieter Glebe; Stephan Urban
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

4.  Quasispecies characters of hepatitis B virus in immunoprophylaxis failure infants.

Authors:  Xin Wang; Wanyan Deng; Keli Qian; Haijun Deng; Yong Huang; Zeng Tu; Ailong Huang; Quanxin Long
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-04-08       Impact factor: 3.267

5.  A case of hepatitis B reactivation in an anti-HBs positive, anti-HBc positive non-Hodgkin's lymphoma patient.

Authors:  Chunchen Wu; Hui Shi; Mengji Lu; Yang Xu; Xinwen Chen
Journal:  Virol Sin       Date:  2013-02-06       Impact factor: 4.327

Review 6.  Genetic variation of hepatitis B virus and its significance for pathogenesis.

Authors:  Zhen-Hua Zhang; Chun-Chen Wu; Xin-Wen Chen; Xu Li; Jun Li; Meng-Ji Lu
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 7.  Hepatitis B vaccination.

Authors:  Luisa Romanò; Sara Paladini; Cristina Galli; Giovanni Raimondo; Teresa Pollicino; Alessandro R Zanetti
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

8.  Epidemic history and evolutionary dynamics of hepatitis B virus infection in two remote communities in rural Nigeria.

Authors:  Joseph C Forbi; Gilberto Vaughan; Michael A Purdy; David S Campo; Guo-liang Xia; Lilia M Ganova-Raeva; Sumathi Ramachandran; Hong Thai; Yury E Khudyakov
Journal:  PLoS One       Date:  2010-07-19       Impact factor: 3.240

9.  Novel assay of competitively differentiated polymerase chain reaction for screening point mutation of hepatitis B virus.

Authors:  Xiao-Mou Peng; Xue-Juan Chen; Jian-Guo Li; Lin Gu; Yang-Su Huang; Zhi-Liang Gao
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

10.  Use of dried blood samples for monitoring hepatitis B virus infection.

Authors:  Rosalia Lira; Angelica Maldonado-Rodriguez; Othon Rojas-Montes; Martha Ruiz-Tachiquin; Rocio Torres-Ibarra; Carlos Cano-Dominguez; Hilda Valdez-Salazar; Alejandro Gomez-Delgado; Onofre Muñoz; Ma-Teresa Alvarez-Muñoz
Journal:  Virol J       Date:  2009-09-29       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.